Lv1
52 积分 2023-11-08 加入
Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network
9小时前
已完结
Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline
10小时前
已完结
Ifupinostat: First Approval
11天前
已完结
In vivo CAR T cells move into clinical trials
2个月前
已完结
Risk Factors for Bacteriuria and Clinical Urinary Tract Infection in Patients Treated with Clean Intermittent Catheterization
2个月前
已完结
肝门部胆管癌诊断和治疗指南（2025版）
4个月前
已完结
[Expert consensus on whole-course management of prostate cancer (2025 edition)]
4个月前
已完结
Modulation of Rb phosphorylation and antiproliferative response to palbociclib: the preoperative-palbociclib (POP) randomized clinical trial
4个月前
已完结
From Hit to Lead: Structure-Based Optimization of Novel Selective Inhibitors of Receptor-Interacting Protein Kinase 1 (RIPK1) for the Treatment of Inflammatory Diseases
5个月前
已完结
Scintigraphic Tracking of Mesenchymal Stem Cells After Intravenous Regional Limb Perfusion and Subcutaneous Administration in the Standing Horse
7个月前
已完结
皖公网安备34019202002308
